These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11063904)

  • 1. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen on serum lipid profile in early menopausal women.
    Itoi H; Minakami H; Iwasaki R; Sato I
    Maturitas; 2000 Oct; 36(3):217-22. PubMed ID: 11063904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women.
    Itoi H; Minakami H; Sato I
    Maturitas; 1997 Sep; 28(1):11-7. PubMed ID: 9391990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
    Yang TS; Wang HL; Chen YJ; Chang SP; Yuan CC
    J Chin Med Assoc; 2004 Jul; 67(7):336-43. PubMed ID: 15510930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of medrogestone on plasma lipids and lipoproteins in postmenopausal women using conjugated estrogens: an open randomized comparative study.
    Gevers Leuven JA; van der Mooren MJ; Buytenhek R
    Fertil Steril; 1995 Sep; 64(3):525-31. PubMed ID: 7641905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activity of lecithin:cholesterol acyltransferase during short-term oral estrogen progestin replacement therapy in a group of postmenopausal women.
    Ulloa N; Verdugo C; Rios M; Sepúlveda J; Sepúlveda S; Naveas R; Calvo C
    Metabolism; 1998 Mar; 47(3):297-300. PubMed ID: 9500566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    N Engl J Med; 1997 Aug; 337(9):595-601. PubMed ID: 9271481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
    Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
    BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phasic serum lipid excursions occur during cyclical oral conjugated oestrogens but not during transdermal oestradiol sequentially combined with oral medroxyprogesterone acetate.
    Lemay A; Dodin S; Cédrin I; T-Lemay L
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):341-51. PubMed ID: 7750187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
    Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women.
    Binder EF; Birge SJ; Kohrt WM
    J Am Geriatr Soc; 1996 Mar; 44(3):231-6. PubMed ID: 8600189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of transdermal and oral estrogens on serum lipids and lipoproteins in postmenopausal women.
    Adami S; Rossini M; Zamberlan N; Bertoldo F; Dorizzi R; Lo Cascio V
    Maturitas; 1993 Nov; 17(3):191-6. PubMed ID: 8133793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent use of simvastatin and estrogen--progestin therapy compared with each therapy alone for hypercholesterolemia in postmenopausal women.
    Darling GM; Johns JA; McCloud PI; Davis SR
    Climacteric; 1999 Sep; 2(3):181-8. PubMed ID: 11910595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R; Urdinola J; Onatra W; Sánchez F; Posso H
    Maturitas; 1999 May; 32(1):41-50. PubMed ID: 10423715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group.
    Pickar JH; Wild RA; Walsh B; Hirvonen E; Lobo RA
    Climacteric; 1998 Mar; 1(1):26-32. PubMed ID: 11913407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.
    Denke MA
    Am J Med; 1995 Jul; 99(1):29-35. PubMed ID: 7598139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women.
    Barnes RB; Roy S; Lobo RA
    Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.